Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Spry

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1996
Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG)J W Denham, B H Burmeister, D S Lamb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1996
Mucosal regeneration during radiotherapy. Trans Tasman Radiation Oncology Group (TROG)J W Denham, Q J Walker, D S Lamb, et al.
Australasian Radiology|May 31, 2001
System validation and work practice efficiency gains of a new localization method for stereotactic radiotherapyM A Ebert, C E Herbert, N A Spry, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1995
Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution studyJ W Denham, C S Hamilton, D Christie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2001
A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group StudyM G Poulsen, J W Denham, L J Peters, et al.
Prostate Cancer and Prostatic Diseases|August 22, 2012
Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective studyN A Spry, D R Taaffe, P J England, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1992
Treatment and planning decisions in non-small cell carcinoma of the lung: an Australasian patterns of practice studyC S Hamilton, J W Denham, D J Joseph, et al.
Pathology|September 2, 2015
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical dataB Delahunt, L Egevad, J R Srigley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 30, 1999
Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?J W Denham, L J Peters, J Johansen, et al.
Pathology|December 27, 2021
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trialB Delahunt, A Steigler, C Atkinson, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1996
Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG)J W Denham, B H Burmeister, D S Lamb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1996
Mucosal regeneration during radiotherapy. Trans Tasman Radiation Oncology Group (TROG)J W Denham, Q J Walker, D S Lamb, et al.
Australasian Radiology|May 31, 2001
System validation and work practice efficiency gains of a new localization method for stereotactic radiotherapyM A Ebert, C E Herbert, N A Spry, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1995
Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution studyJ W Denham, C S Hamilton, D Christie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2001
A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group StudyM G Poulsen, J W Denham, L J Peters, et al.
Prostate Cancer and Prostatic Diseases|August 22, 2012
Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective studyN A Spry, D R Taaffe, P J England, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1992
Treatment and planning decisions in non-small cell carcinoma of the lung: an Australasian patterns of practice studyC S Hamilton, J W Denham, D J Joseph, et al.
Pathology|September 2, 2015
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical dataB Delahunt, L Egevad, J R Srigley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 30, 1999
Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?J W Denham, L J Peters, J Johansen, et al.
Pathology|December 27, 2021
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trialB Delahunt, A Steigler, C Atkinson, et al.
Pageof 3